35 related articles for article (PubMed ID: 34127243)
1. PGMC: a framework for probabilistic graphic model combination.
Jiang CA; Leong TY; Poh KL
AMIA Annu Symp Proc; 2005; 2005():370-4. PubMed ID: 16779064
[TBL] [Abstract][Full Text] [Related]
2. [Cost-effectiveness analysis: a framework for prioritisation criteria].
Bjørnelv GMW; Aas E
Tidsskr Nor Laegeforen; 2023 Nov; 143(16):. PubMed ID: 37938016
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness of severe acute malnutrition treatment delivered by community health workers in the district of Mayahi, Niger.
Molanes-López EM; Ferrer JM; Dougnon AO; Gado AA; Sanoussi A; Ousmane N; Lazoumar RH; Charle-Cuéllar P
Hum Resour Health; 2024 Mar; 22(1):22. PubMed ID: 38553707
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness Analysis with Influence Diagrams.
Arias M; Díez FJ
Methods Inf Med; 2015; 54(4):353-8. PubMed ID: 25762363
[TBL] [Abstract][Full Text] [Related]
5. Markov Influence Diagrams.
Díez FJ; Yebra M; Bermejo I; Palacios-Alonso MA; Calleja MA; Luque M; Pérez-Martín J
Med Decis Making; 2017 Feb; 37(2):183-195. PubMed ID: 28076183
[TBL] [Abstract][Full Text] [Related]
6. Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.
Stenehjem DD; Bellows BK; Yager KM; Jones J; Kaldate R; Siebert U; Brixner DI
Oncologist; 2016 Feb; 21(2):196-204. PubMed ID: 26614710
[TBL] [Abstract][Full Text] [Related]
7. Use of influence diagrams to structure medical decisions.
Nease RF; Owens DK
Med Decis Making; 1997; 17(3):263-75. PubMed ID: 9219186
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis with unordered decisions.
Díez FJ; Luque M; Arias M; Pérez-Martín J
Artif Intell Med; 2021 Jul; 117():102064. PubMed ID: 34127243
[TBL] [Abstract][Full Text] [Related]
9. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
10. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
11. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
